SLDB Latest Headlines

J.P. Morgan Issues a Buy Rating on Solid Biosciences (SLDB)

at www.tipranks.com (Wed, 25-Mar 7:16 AM)

3 Best Stocks to Buy Today, 3/23/2026, According to Top Analysts

at www.tipranks.com (Mon, 23-Mar 11:07 AM)

Analysts Offer Insights on Healthcare Companies: Beta Bionics, Inc. (BBNX), Apogee Therapeutics (APGE) and Solid Biosciences (SLDB)

at www.tipranks.com (Mon, 23-Mar 8:50 AM)

Solid Biosciences: Strong SGT-003 Clinical Profile, Emerging Pipeline, and Robust Cash Runway Underpin Buy Rating

at www.tipranks.com (Mon, 23-Mar 6:16 AM)

Solid Biosciences Showcases Next-Generation Gene Therapies with Key Data at 2026 MDA Conference

Market Chameleon (Mon, 9-Mar 11:19 AM)

Solid Biosciences Highlights Clinical Momentum in Gene Therapies Ahead of Key 2026 MDA Conference Presentation

Market Chameleon (Fri, 6-Mar 11:45 AM)

Solid Biosciences Lands $240 Million Oversubscribed Private Placement—Institutional Backing Fuels Ambitions in Genetic Medicine

Market Chameleon (Fri, 6-Mar 9:07 AM)

FDA Grants Orphan Drug Status to SLDB’s Novel Gene Therapy for Friedreich's Ataxia—What Does This Mean for Patients?

Market Chameleon (Tue, 13-Jan 8:38 AM)